Literature DB >> 8123408

Effect of renal failure on drug metabolism by the liver.

A C Elston1, M K Bayliss, G R Park.   

Abstract

Entities:  

Mesh：

Year:  1993        PMID： 8123408     DOI： 10.1093/bja/71.2.282

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN： 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  20 in total

Review 1.  Pharmacokinetics of continuous renal replacement therapy.

Authors:  M Schetz; P Ferdinande; G Van den Berghe; C Verwaest; P Lauwers
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 2.  Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock.

Authors:  Peter De Paepe; Frans M Belpaire; Walter A Buylaert
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 3.  Consequences of renal failure on non-renal clearance of drugs.

Authors:  Laure Lalande; Bruno Charpiat; Gilles Leboucher; Michel Tod
Journal:  Clin Pharmacokinet       Date:  2014-06       Impact factor: 6.447

4.  Sources of Interindividual Variability.

Authors:  Yvonne S Lin; Kenneth E Thummel; Brice D Thompson; Rheem A Totah; Christi W Cho
Journal:  Methods Mol Biol       Date:  2021

5.  Pronounced influence of presystemic metabolism on the metabolic disposition of imrecoxib in renally impaired patients.

Authors:  Nuggehally R Srinivas
Journal:  Eur J Clin Pharmacol       Date:  2020-01-03       Impact factor: 2.953

Review 6.  Pharmacokinetics of drugs used in critically ill adults.

Authors:  B M Power; A M Forbes; P V van Heerden; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1998-01       Impact factor: 6.447

7.  Warfarin dosing in patients with impaired kidney function.

Authors:  Nita A Limdi; Mohit A Limdi; Larisa Cavallari; Aaron M Anderson; Michael R Crowley; Melissa F Baird; Michael Allon; T Mark Beasley
Journal:  Am J Kidney Dis       Date:  2010-08-14       Impact factor: 8.860

8.  The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.

Authors:  Samir K Gupta; Susan L Rosenkranz; Yoninah S Cramer; Susan L Koletar; Lynda A Szczech; Valerianna Amorosa; Stephen D Hall
Journal:  AIDS       Date:  2008-10-01       Impact factor: 4.177

Review 9.  The effect of chronic renal failure on drug metabolism and transport.

Authors:  Albert W Dreisbach; Juan J L Lertora
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-08       Impact factor: 4.481

Review 10.  Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Authors:  G R Matzke; R F Frye
Journal:  Drug Saf       Date:  1997-03       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.